Eukles Asset Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-4
Closed -$285 – 234
2026
Q1
$285 Buy
+4
New +$315 ﹤0.01% 226
2025
Q4
– Sell
-7
Closed -$526 – 235
2025
Q3
$526 Hold
7
– – ﹤0.01% 228
2025
Q2
$518 Hold
7
– – ﹤0.01% 225
2025
Q1
$565 Hold
7
– – ﹤0.01% 207
2024
Q4
$547 Hold
7
– – ﹤0.01% 213
2024
Q3
$657 Hold
7
– – ﹤0.01% 225
2024
Q2
$545 Hold
7
– – ﹤0.01% 223
2024
Q1
$636 Hold
7
– – ﹤0.01% 221
2023
Q4
$541 Hold
7
– – ﹤0.01% 230
2023
Q3
$476 Buy
+7
New +$509 ﹤0.01% 228

Other funds holding GEHC

Eukles Asset Management's GEHC Position: Q2 2026 in Review

Eukles Asset Management sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 4 shares — an estimated $285 sold.

Eukles Asset Management first reported a position in GEHC in Q3 2023 and held it in 10 quarters. The position peaked at $657 in Q3 2024. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Eukles Asset Management reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Eukles Asset Management sold 4 GE HealthCare shares in Q2 2026, an estimated $285.
  • Eukles Asset Management first reported a position in GE HealthCare in Q3 2023 and held it in 10 quarters.
  • Eukles Asset Management's GE HealthCare position peaked at $657 in Q3 2024.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Eukles Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.